Essity (LSE:0RQC) - Aandelenkoers, Nieuws & Analyse

0RQC Overzicht aandelen

Essity AB (publ) ontwikkelt, produceert en verkoopt hygiëne- en gezondheidsproducten en -diensten in Europa, Noord- en Latijns-Amerika en Azië. Meer informatie

0RQC fundamentele analyse
Sneeuwvlok Score
Waardering	4/6
Toekomstige groei	1/6
Prestaties in het verleden	4/6
Financiële gezondheid	6/6
Dividenden	3/6

Beloningen

Verhandeld tegen 46% onder onze schatting van de reële waarde

De winst zal naar verwachting met 6.02% per jaar groeien

De winst groeide het afgelopen jaar met 51.3%

Risicoanalyse

Geen risico's gedetecteerd voor 0RQC uit onze risicocontroles.

Essity AB (publ) Concurrenten

Reckitt Benckiser Group

LSE:RKT

UK£33.4b

McBride

LSE:MCB

UK£182.8m

Haleon

LSE:HLN

UK£34.4b

Clorox

NYSE:CLX

US$21.0b

Prijsgeschiedenis en prestaties

Overzicht van alle hoogtepunten, veranderingen en prijsdalingen voor Essity
Historische aandelenkoersen
Huidige aandelenkoers	SEK 297.50
52 Week Hoogtepunt	SEK 323.50
52 Week Laag	SEK 235.00
Bèta	0.21
11 maand verandering	-1.82%
3 maanden verandering	-1.65%
1 Jaar Verandering	13.55%
33 jaar verandering	1.88%
5 jaar verandering	0%
Verandering sinds IPO	34.85%

Recent nieuws en updates

Recent updates

Rendement voor aandeelhouders

	0RQC	GB Household Products	GB Markt
7D	0.5%	0.8%	1.7%
1Y	13.5%	1.3%	8.3%

Rendement versus industrie: 0RQC overtrof de UK Household Products industrie, die het afgelopen jaar een rendement 1.3 % opleverde.

Rendement versus markt: 0RQC overtrof de UK markt, die het afgelopen jaar een rendement opleverde van 8.3 %.

Prijsvolatiliteit

Is 0RQC's price volatile compared to industry and market?
0RQC volatility
0RQC Average Weekly Movement	2.4%
Household Products Industry Average Movement	3.8%
Market Average Movement	4.8%
10% most volatile stocks in GB Market	10.3%
10% least volatile stocks in GB Market	2.6%

Stabiele aandelenkoers: 0RQC heeft de afgelopen 3 maanden geen significante prijsvolatiliteit gekend.

Volatiliteit in de loop van de tijd: De wekelijkse volatiliteit ( 2% ) van 0RQC is het afgelopen jaar stabiel geweest.

Over het bedrijf

Opgericht	Werknemers	CEO	Website
1849	36,000	Magnus Groth	www.essity.com

Essity AB (publ) ontwikkelt, produceert en verkoopt hygiëne- en gezondheidsproducten en -diensten in Europa, Noord- en Latijns-Amerika, Azië en internationaal. Het bedrijf is actief in de segmenten Health & Medical, Consumer Goods en Professional Hygiene. Het segment Gezondheid & Medisch biedt incontinentieproducten, wondverzorging, compressietherapie, orthopedie, huidverzorgingsproducten, vochtige doekjes, washandjes en digitale oplossingen met sensortechnologie onder de merknamen TENA, Leukoplast, JOBST, Actimove, Cutimed, Delta-Cast, AquaCast Liner en Hydrofera aan gezinsverzorgers, professionele zorgverleners en patiënten en consumenten via apotheken, winkels voor medische hulpmiddelen, ziekenhuizen, distributeurs, zorginstellingen en e-commerce.

Essity AB (publ) Samenvatting

Hoe verhouden de winst en inkomsten van Essity zich tot de beurswaarde?
0RQC fundamentele statistieken
Marktkapitalisatie	SEK 210.52b
Inkomsten(TTM)	SEK 11.79b
Inkomsten(TTM)	SEK 144.37b

17.8x

Koers/Winstverhouding

1.5x

P/S-verhouding

Is 0RQC overgewaardeerd?

Zie Reële waarde en waarderingsanalyse

Inkomsten en omzet

Belangrijkste winstgevendheidsstatistieken uit het laatste winstverslag (TTM)
0RQC resultatenrekening (TTM)
Inkomsten	SEK 144.37b
Kosten van inkomsten	SEK 97.10b
Brutowinst	SEK 47.26b
Overige uitgaven	SEK 35.47b
Inkomsten	SEK 11.79b

Laatst gerapporteerde inkomsten

Sep 30, 2024

Volgende inkomensdatum

Jan 23, 2025

Winst per aandeel (EPS)	16.93
Brutomarge	32.74%
Nettowinstmarge	8.17%
Schuld/Eigen Vermogen Verhouding	56.7%

Hoe presteerde 0RQC op de lange termijn?

Bekijk historische prestaties en vergelijking

Dividenden

2.6%

Huidig dividendrendement

46%

Uitbetalingsratio

0RQC Overzicht aandelen

Beloningen

Risicoanalyse

Essity AB (publ) Concurrenten

LSE:RKT

UK£33.4b

LSE:MCB

UK£182.8m

LSE:HLN

UK£34.4b

NYSE:CLX

US$21.0b

Prijsgeschiedenis en prestaties

Recent nieuws en updates

Essity Receives Demand for Early Repayment of Bonds

Essity Receives Demand for Early Repayment of Bonds

Essity AB (publ) to Report Fiscal Year 2024 Results on Jan 23, 2025

Essity AB (Publ) Approves Dividend for the Fiscal Year 2023, Payable on March 28, 2024

Essity AB (publ) Proposes Dividend for the Year 2023, Payable on March 28, 2024

Essity Launches Caressa - Digital Platform to Assist Family Carers

Recent updates

Essity Receives Demand for Early Repayment of Bonds

Essity Receives Demand for Early Repayment of Bonds

Essity AB (publ) to Report Fiscal Year 2024 Results on Jan 23, 2025

Essity AB (Publ) Approves Dividend for the Fiscal Year 2023, Payable on March 28, 2024

Essity AB (publ) Proposes Dividend for the Year 2023, Payable on March 28, 2024

Essity Launches Caressa - Digital Platform to Assist Family Carers

Essity AB (publ) to Report Q4, 2023 Results on Feb 26, 2024

Essity AB (publ) to Report Nine Months, 2024 Results on Oct 24, 2024

Essity Aktiebolag (Publ) Announces Current Chairman of the Board, Pär Boman, Declined Re-Election

Essity Chairman Pär Boman Declines Re-Election

Essity Appoints Sandra Åberg as Head of Investor Relations, Effective September 1, 2023

New Technologies LLC acquired Russian operations from Essity AB (publ) (OM:ESSITY B) for SEK 1.2 billion.

Essity Announces the Launch of Sensitive Caretm Pads

An unknown buyer agreed to acquire Russian operations from Essity AB (publ) (OM:ESSITY B).

Essity Announces Executive Changes

Essity AB (publ) to Report Q3, 2023 Results on Oct 26, 2023

Essity AB (publ) Launches Issviva - A New Brand for Women+ Experiencing Menopause

Essity Announces Executive Changes

Essity AB (Publ) Announces Resignation of Don Lewis as President of Professional Hygiene

Essity AB (publ) to Report Fiscal Year 2022 Final Results on Mar 01, 2023

Essity AB (publ) (OM:ESSITY B) completed the acquisition of 80% stake in Knix Wear Inc.

Essity AB (publ) (OM:ESSITY B) agreed to acquire 80% stake in Knix Wear Inc. for approximately SEK 3.3 billion.

Essity AB (publ) (OM:ESSITY B) agreed to acquire Modibodi Pty Ltd for AUD 140 million.

Essity AB (publ) to Report Fiscal Year 2022 Results on Jan 26, 2023

Essity AB (publ) (OM:ESSITY B) acquired Legacy Converting Inc. for $50 million.

Essity AB (publ) (OM:ESSITY B) made an offer to acquire remaining 4.19% stake in Productos Familia S.A. (BVC:FAMILIA).

Essity AB (Publ) Provides Guidance for 2022

Essity AB (publ) (OM:ESSITY B) acquired Aquacast Liner Llc.

Essity Begins Tissue Production from Alternative Fibers

Essity AB (publ) (OM:ESSITY B) completed the acquisition of additional 45.8% stake in Productos Familia S.A. (BVC:FAMILIA).

Essity Launches TENA Stylish Incontinence Underwear Exclusively At Walmart

Essity Launches Libresse V-Cup

Essity's Cutimed® Sorbact® Advanced Wound Care Products Receive Innovative Technology Contract From Vizient, Inc

Essity AB (Publ) Announces Maija-Liisa Friman Is Not Available for Re-Election

Asaleo Care Reportedly Grants Limited Due Diligence to Essity

Essity AB (publ) to Report Fiscal Year 2020 Final Results on Mar 01, 2021

Essity AB (publ)'s Tork Solutions Help Manufacturers Secure the New Hygiene Standard

Essity AB (publ) (OM:ESSITY B) made a nonbinding indicative proposal to acquire remaining 63.8% stake in Asaleo Care Limited (ASX:AHY) for approximately AUD 440 million.

Essity Launches New Digital Incontinence Care Solution

Essity Launches Face Masks for Consumers and Professional Users

Essity Boosts Hand Sanitizer Capacity in Europe

Essity AB (publ) to Report Q3, 2020 Results on Oct 22, 2020

Essity AB (publ) (OM:ESSITY B) acquired NovioScan B.V. for €6.5 million.

Essity AB (publ) (OM:ESSITY B) completed the acquisition of 75% stake in ABIGO Medical AB for SEK 642 million.

Rendement voor aandeelhouders

Prijsvolatiliteit

Over het bedrijf

Essity AB (publ) Samenvatting

17.8x

1.5x

Inkomsten en omzet

Dividenden

2.6%

46%